Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 134 results for "glenmark"

105 images for glenmark

Money Control, 3 days ago
Money Control, 1 week ago
catchnews.com, 3 days ago
Money Control, 2 weeks ago
Money Control, 3 weeks ago
DNA, 2 weeks ago
Livemint.com, 1 month ago
India Infoline, 1 month ago
India.com, 1 month ago
Livemint.com, 1 month ago
Money Control

Glenmark rises 4% on receipt of inspection report from US FDA

The drug firm received establishment inspection report (EIR) from the US Food and Drug Administration on closure of inspection of its Ankleshwar plant in Gujarat.
 Money Control1 week ago Glenmark's Ankleshwar plant gets EIR report from USFDA  DNA1 week ago Glenmark Pharma receives EIR from USFDA for Ankleshwar plant  Myiris1 week ago Glenmark#39;s Ankleshwar plant gets EIR report from USFDA  Money Control1 week ago
[x]  

Sell Tata Motors, Glenmark Pharma; buy Colgate Palmolive: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com suggests selling Tata Motors and Glenmark Pharma and advises buying Colgate Palmolive.
 Money Control2 days ago Buy Glenmark, Snowman Logistics, Suven Life; sell MRF: Thakkar  Money Control1 month ago Stocks in news: BSE, Tata Power, Glenmark, Sun TV, Ujjivan  Money Control1 month ago Buy Just Dial, Glenmark Pharma, NCC: Mitessh Thakkar  Money Control1 month ago
Money Control

Glenmark ties up with Evestra to develop contraceptive

The companies will file for product approval in FY19
 Business Standard3 weeks ago Glenmark, Evestra enter pact for generic contraceptive product  Money Control3 weeks ago Glenmark partners Evestra to market contraceptive product in US  Business Standard3 weeks ago Glenmark Pharma, Evestra ink pact for generic NuvaRing  Myiris3 weeks ago
Money Control

USFDA clears Glenmark's investigational new drug application

Drug major Glenmark today said theUS health regulator has cleared its investigational new drug(IND) application to begin a phase two study of GSP 304 to beused for treatment of a respiratory disease.
 Money Control2 weeks ago Glenmark Pharma receives USFDA nod for IND GSP 304  Myiris2 weeks ago Glenmark Pharma up 1% on US FDA nod to drug's first phase  Money Control2 weeks ago Sanofi sues Glenmark, Torrent over sclerosis drug  Business Standard2 months ago
[x]  

Buy Just Dial; sell CONCOR, Glenmark Pharma: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com is of the view that one can buy Just Dial and sell Container Corporation of India and Glenmark Pharma.
 Money Control1 month ago Buy Adani Enterprises, IGL; sell Glenmark Pharma: Sandeep Wagle  Money Control1 month ago Buy Sun TV, Ujjivan Financial, Glenmark, Bajaj Finserv: Gujral  Money Control1 month ago Buy Zee Entertainment, Hindalco; sell Glenmark: Ashwani Gujral  Money Control1 month ago
Forbes India

Glenmark Q3 FY17 net rises by 143%

Robust operating performance in the US business helps Glenmark post stellar earnings in an otherwise forgettable quarter for Indian pharma By Aveek Datta Forbes India Staff Published: Feb 2, 2017 Full Bio Image: Vikas Khot Mumbai-based generic drug maker ...
 Forbes India1 month ago Glenmark Pharma soars above 5% taking cues from its Q3 results  India Infoline1 month ago Glenmark Q3 net soars 143% to Rs 477 cr aided by US generic biz  Money Control1 month ago Glenmark Q3 net up over two-fold to Rs 477 cr  DNA1 month ago

Glenmark rises 7% on strong Q3 nos; US formulation sales up 102%

The company has registered 102 percent rise in its US formulation sales at Rs 1,231 crore, while India formulation sales was up 5.9 percent at Rs 516.8 crore.
 Money Control1 month ago Glenmark Pharma Q3 PAT seen up 37% to Rs 310 cr: HDFC Securities  Money Control2 months ago Glenmark Q3 PAT seen up 62.6% to Rs 363.5 cr: ICICI Securities  Money Control2 months ago

Glenmark Pharma gets earnings boost

The shares of Glenmark Pharmaceuticals surged about 7 per cent in early trades on Friday on the back of strong third-quarter (Q3) earnings. The stock recorded a high of 970 and has come-off from there to current levels of 950 (up 4.6 per cent). The drug ...
 Business Line1 month ago Glenmark Pharma climbs nearly 7% on smart Q3 earnings  DNA1 month ago

Glenmark Pharma may touch Rs 1000: Rajat Bose

Rajat Bose of rajatkbose.com feels that Glenmark Pharma may touch Rs 1000.
 Money Control1 month ago Buy ILFS Transport, Glenmark Pharma: Rajat Bose  Money Control2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less